Pneumatosis Cystoides Intestinalis Secondary to Antibiotic Therapy for Pulmonary Mycobacterium avium Complex Infection: A Case Report and Review of the Literature.

Intern MedJan 15, 2026 (epub)

Koki Nakashima, Hiroki Matsukawa, Toshiko Kakiuchi et al.

✦ AI-curated · Sources linked

Case in brief

An 83-year-old woman receiving antibiotic therapy for pulmonary Mycobacterium avium complex infection developed pneumatosis cystoides intestinalis (PCI), characterized by gas within the gastrointestinal wall. PCI improved after the antibiotics were discontinued. The authors considered the clinical course potentially consistent with an association between long-term antibiotic therapy and PCI, while noting that the mechanism is unclear.

What made this case unusual

PCI developed during long-term antibiotic treatment for pulmonary MAC infection, an association the report describes as rarely observed.

Diagnostic / clinical pearl

In a patient receiving long-term antibiotics for pulmonary MAC infection, consider PCI if gas is found in the gastrointestinal wall; improvement after stopping antibiotics may support a possible treatment association.

Source

Published in Intern Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.